Similar trends were observed in the baseline abundance of CD4+ and CD8 + T cells, although these differences did not reach statistical significance (Supplementary Fig. 7 ).
← all excerpts
Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trial.
1
—
—